经导管主动脉瓣植入术治疗重度主动脉瓣狭窄患者的初步经验Transcatheter aortic valve implantation:the preliminary experience from West China Hospital
陈茂,冯沅,唐红,魏薪,赵振刚,徐原宁,廖延标,黄德嘉
摘要(Abstract):
目的分享经导管主动脉瓣植入术(TAVI)治疗重度主动脉瓣狭窄患者的经验。方法分析已完成TAVI患者的基线特征、术后血流动力学变化情况及临床结果。结果 2012年4月至2014年3月共36例患者于四川大学华西医院进行TAVI,平均年龄(73.9±7.2)岁,其中男24例(66.7%),平均欧洲心脏手术风险回归评分为(20.6±9.9)%。25例(69.4%)患者主动脉瓣叶形态呈二叶式畸形。TAVI成功35例(97.2%),4例(11.1%)需植入第2枚瓣膜。术后主动脉瓣平均跨瓣压差下降至(10.5±5.7)mmHg(1 mmHg=0.133 kPa),2例残余瓣周漏接近中度。术后30 d内死亡1例(2.8%),脑卒中2例(5.6%)。10例(27.8%)患者因出现Ⅲ度房室传导阻滞而植入了永久起搏器。中位随访时间323 d,除2例患者分别于术后374 d和680 d死于恶性肿瘤外,其余患者均保持无症状生存。结论对于不适合进行外科手术的二叶式和三叶式主动脉瓣重度狭窄患者,TAVI是可行、安全和有效的。
关键词(KeyWords): 主动脉瓣狭窄;二叶式主动脉瓣;经导管主动脉瓣植入术
基金项目(Foundation):
作者(Author): 陈茂,冯沅,唐红,魏薪,赵振刚,徐原宁,廖延标,黄德嘉
参考文献(References):
- [1]Nishimura RA,Otto CM,Bonow RO,et al.2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease:A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.Circulation,2014,129:e521-e643.
- [2]Nkomo VT,Gardin JM,Skelton TN,et al.Burden of valvular heart diseases:a population-based study.Lancet,2006,368:1005-1011.
- [3]Turina J,Hess O,Sepulcri F,et al.Spontaneous course of aortic valve disease.Eur Heart J,1987,8:471-483.
- [4]Kelly TA,Rothbart RM,Cooper CM,et al.Comparison of outcome of asymptomatic to symptomatic patients older than 20 years of age with valvular aortic stenosis.Am J Cardiol,1988,61:123-130.
- [5]Iung B,Cachier A,Baron G,et al.Decision-making in elderly patients with severe aortic stenosis:why are so many denied surgeryEur Heart J,2005,26:2714-2720.
- [6]Cribier A,Eltchaninoff H,Bash A,et al.Percutaneous transcatheter implantation of an aortic valve prosthesis for calcifi c aortic stenosis:fi rst human case description.Circulation,2002,106:3006-3008.
- [7]Leon MB,Smith CR,Mack M,et al.Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.N Engl J Med,2010,363:1597-1607.
- [8]Smith CR,Leon MB,Mack MJ,et al.Transcatheter versus surgical aortic-valve replacement in high-risk patients.N Engl J Med,2011,364:2187-2198.
- [9]葛均波,周达新,潘文志,等.经皮主动脉瓣植入术一例及其操作要点.中国介入心脏病学杂志,2010,18:243-246.
- [10]秦永文.评国内首例经导管主动脉瓣膜植入术成功.中国介入心脏病学杂志,2010,18:241-242.
- [11]陈茂,冯沅,唐红,等.经导管主动脉瓣植入术三例.华西医学,2012,27:1119-1120.
- [12]Grube E,Laborde JC,Gerckens U,et al.Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease:the Siegburg fi rst-in-man study.Circulation,2006,114:1616-1624.
- [13]Zegdi R,Ciobotaru V,Noghin M,et al.Is it reasonable to treat all calcified stenotic aortic valves with a valved stentResults from a human anatomic study in adults.J Am Coll Cardiol,2008,51:579-584.
- [14]Himbert D,Pontnau F,Messika-Zeitoun D,et al.Feasibility and outcomes of transcatheter aortic valve implantation in high-risk patients with stenotic bicuspid aortic valves.Am J Cardiol,2012,110:877-883.
- [15]Wijesinghe N,Ye J,Rodes-Cabau J,et al.Transcatheter aortic valve implantation in patients with bicuspid aortic valve stenosis.JACC Cardiovasc Interv,2010,3:1122-1125.
- [16]Hayashida K,Bouvier E,Lefevre T,et al.Transcatheter aortic valve implantation for patients with severe bicuspid aortic valve stenosis.Circ Cardiovasc Interv,2013,6:284-291.
- [17]Bauer T,Linke A,Sievert H,et al.Comparison of the effectiveness of transcatheter aortic valve implantation in patients with stenotic bicuspid versus tricuspid aortic valves(from the German TAVI Registry).Am J Cardiol,2014,113:518-521.
- [18]Costopoulos C,Latib A,Maisano F,et al.Comparison of results of transcatheter aortic valve implantation in patients with severely stenotic bicuspid versus tricuspid or nonbicuspid valves.Am J Cardiol,2014,113:1390-1393.
- [19]Dvir D,Webb JG,Bleiziffer S,et al.Transcatheter aortic valve implantation in failed bioprosthetic surgical valves.JAMA,2014,312:162-170.
- [20]Piazza N,Kalesan B,van Mieghem N,et al.A 3-center comparison of 1-year mortality outcomes between transcatheter aortic valve implantation and surgical aortic valve replacement on the basis of propensity score matching among intermediate-risk surgical patients.JACC Cardiovasc Interv,2013,6:443-451.